Current market catalysts

This Ormat Technologies Analyst Is No Longer Bearish; Here Are Top 3 Upgrades For Friday

Analysts upgraded ORA, WPC, and more with higher price targets.

Gold Falls Over 1%; American Outdoor Brands Shares Jump After Q1 Results

U.S. stocks fell as August jobs beat estimates; oil, gold and silver declined. Immuron, Quanex and AOUT surged, while GWRE, LULU and PATH dropped.

Morgan Stanley Maintains Equal-Weight on Docusign, Raises Price Target to $75

JP Morgan Maintains Overweight on Saia, Lowers Price Target to $490

JP Morgan Maintains Overweight on Ciena, Lowers Price Target to $605

Morgan Stanley Maintains Equal-Weight on Ciena, Lowers Price Target to $425

Shares of crypto-related companies are trading lower amid a decline in Bitcoin prices following August's hotter-than-expected payrolls report, which boosted expectations for a potential Federal Reserve rate hike at its next meeting. A stronger U.S. dollar and higher interest-rate expectations are further weighing on crypto and other risk assets by reducing investor appetite for speculative investments.

Microsoft Stock: Why Satya Nadella's $44 Million Sale May Not Spook Investors

Satya Nadella's planned $44M Microsoft stock sale may not rattle investors. Here's why the market could look past the SEC filing.

CORRECTION: Planet Labs Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $116.052M Beat $104.118M Estimate

Planet Labs (NYSE:PL) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 300 percent increase over losses of $(0.01) per share from the same

8-K filing — ASA Gold & Precious Metals Ltd (ASA)

Filed: 2026-09-04 AccNo: 0001398344-26-016643 Size: 204 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

'Rivian Rolls Out RivianOS 2, Unifying Software Across R1 And R2' - Electrek

https://electrek.co/2026/09/04/rivian-rivianos-2-software-update-r1-r2/

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $45 price target.

These Analysts Revise Their Forecasts On Campbell's Following Q4 Results

Campbell’s misses Q4 sales, guides FY27 EPS below estimates; shares drop 2.9% as analysts cut price targets amid softness and inflation.

Raymond James Maintains Outperform on Chewy, Raises Price Target to $28

Raymond James analyst Rick Patel maintains Chewy (NYSE:CHWY) with a Outperform and raises the price target from $25 to $28.

JP Morgan Maintains Neutral on Samsara, Raises Price Target to $52

JP Morgan analyst Alexei Gogolev maintains Samsara (NYSE:IOT) with a Neutral and raises the price target from $48 to $52.

Shopify Q2 2026 Earnings Call Transcript

Shopify (TSX:SHOP) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

Raymond James Initiates Coverage On Capital Bancorp with Market Perform Rating

Raymond James analyst Joseph Yanchunis initiates coverage on Capital Bancorp (NASDAQ:CBNK) with a Market Perform rating.

JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58

If You Invested $100 In Howmet Aerospace Stock 5 Years Ago, You Would Have This Much Today

Howmet Aerospace (NYSE:HWM) has outperformed the market over the past 5 years by 41.45% on an annualized basis producing an average annual return of 52.72%. Currently, Howmet Aerospace has a market capitalization of

Musk’s xAI Loses Court Bid To Block Minnesota's New AI Nudification Restrictions

Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target

Oppenheimer Maintains Outperform on Guidewire Software, Raises Price Target to $210

This Cal-Maine Foods Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Analysts downgraded UiPath, Cal-Maine with several price-target cuts.

Mizuho Maintains Outperform on Chewy, Lowers Price Target to $32

Mizuho Maintains Neutral on Intel, Lowers Price Target to $92

Agile Faces Tough Road To Restructuring

Latest earnings figures show the real estate conglomerate remains mired in a liquidity crisis, while facing a court test and an impending payment crunch image credit: Bamboo works Key Takeaways: At end of

8-K filing — SABINE ROYALTY TRUST (SBR)

Filed: 2026-09-04 AccNo: 0001193125-26-383179 Size: 80 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Mizuho Maintains Neutral on UiPath, Raises Price Target to $14

Quanex Building Prods Q3 2026 Earnings Call: Complete Transcript

Quanex Building Prods (NYSE:NX) released third-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

8-K filing — FORTRESS CREDIT REALTY INCOME TRUST

Filed: 2026-09-04 AccNo: 0001193125-26-383170 Size: 274 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events